mCRPC or Advanced/Metastatic Solid Tumors

Explore clinical trials studying mCRPC or Advanced/Metastatic Solid Tumors. Study availability and eligibility vary by location and protocol.

3 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

mCRPC or Advanced/Metastatic Solid Tumors trial results

Recruiting

NCT07533708

Conditions: mCRPC or Advanced/Metastatic Solid Tumors
Locations: The First Affiliated Hospital of Nanchang University Nanchang, China

Guangxi Medical University Cancer Hospital Naning, China

Nanjing Drum Tower Hospital Nanjing, China

Fudan University Shanghai Cancer Center Shanghai, China

Recruiting

NCT07719361

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +15 more
Locations: START Los Angeles Los Angeles, California, United States

Massachusetts General Hospital Boston, Massachusetts, United States

START Midwest Grand Rapids, Michigan, United States

START New Jersey East Brunswick, New Jersey, United States

Completed

NCT03453528

Conditions: Prostate-specific Membrane Antigen, mCRPC or Advanced/Metastatic Solid Tumors
Locations: Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Meldola, FC, Italy